Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007156779> ?p ?o ?g. }
- W2007156779 endingPage "754" @default.
- W2007156779 startingPage "748" @default.
- W2007156779 abstract "Of 84 renal transplants performed in our center since 1986, six recipients (7.1%) developed posttransplant lymphoproliferative disorder (PTLD). All received quadruple immunosuppression with Minnesota anti-lymphoblastic globulin or anti-thymocyte globulin, methylprednisolone, cyclosporine, and azathioprine or mycophenolate mofetil. Five were seronegative for Epstein-Barr virus (EBV) when they received their renal transplant. All patients received prophylactic acyclovir treatment postrenal transplant and none developed a cytomegalovirus (CMV) infection. All patients were positive for EBV by serology and polymerase chain reaction at the time of diagnosis of PTLD. Clinical features at presentation included fever (6/6), adenopathy (4/6), hypertrophied adenoids (4/6), liver involvement (2/6), and allograft involvement (2/6), 2-78 months (4/6<6 months) postrenal transplant. Histopathology of PTLD tissue revealed T cell rich/ Hodgkin disease-like B cell PTLD in one patient, polymorphic PTLD in four, and monomorphic (large B cell lymphoma) PTLD in one. Immunophenotyping of the PTLD biopsy specimen revealed predominant T cells in three, mixed B and T cells in two patients, and B cell in one. No aneuploid populations were identified by flow cytometric DNA ploidy assay. DNA from the PTLD tissue revealed weak to moderate IgH gene rearrangement in four of six patients but no T cell receptor beta-chain or c-myc gene rearrangement on Southern blot analysis. The child with monomorphic (large B cell lymphoma) PTLD was clonal with lambda light chain restriction on immunophenotyping. Treatment consisted of reduced immunosuppression and ganciclovir/ acyclovir in all patients. CMV hyperimmune globulin was used as an adjunctive therapy in two patients. Chemotherapy was needed in only one patient. A single rejection episode occurred in two children following reduction in immunosuppression, which reversed following intravenous methylprednisolone therapy. PTLD resolved in all patients and at present all patients are alive with functional grafts 2-54 months post diagnosis. Our experience suggests that reduced immunosuppression and anti-viral treatment is adequate in most cases of PTLD, but chemotherapy and hyperimmune globulin therapy may be beneficial in cases resistant to first-line therapy. Since all but one of our patients were EBV seronegative at the time of transplant, vigilance is especially important for early detection of PTLD in this group of the pediatric renal transplant population." @default.
- W2007156779 created "2016-06-24" @default.
- W2007156779 creator A5027825347 @default.
- W2007156779 creator A5057866558 @default.
- W2007156779 creator A5069748177 @default.
- W2007156779 creator A5083465048 @default.
- W2007156779 date "1999-11-01" @default.
- W2007156779 modified "2023-09-30" @default.
- W2007156779 title "Posttransplant lymphoproliferative disorder in pediatric renal transplantation" @default.
- W2007156779 cites W143239180 @default.
- W2007156779 cites W1539347153 @default.
- W2007156779 cites W1933173616 @default.
- W2007156779 cites W1991326196 @default.
- W2007156779 cites W2001123146 @default.
- W2007156779 cites W201435860 @default.
- W2007156779 cites W2015545947 @default.
- W2007156779 cites W2018818484 @default.
- W2007156779 cites W2031832264 @default.
- W2007156779 cites W2032383891 @default.
- W2007156779 cites W2032972450 @default.
- W2007156779 cites W2055680398 @default.
- W2007156779 cites W2056549675 @default.
- W2007156779 cites W2058768523 @default.
- W2007156779 cites W2077002010 @default.
- W2007156779 cites W2112276914 @default.
- W2007156779 cites W2148185719 @default.
- W2007156779 cites W2154191201 @default.
- W2007156779 cites W2165733412 @default.
- W2007156779 cites W2171464968 @default.
- W2007156779 cites W2261378854 @default.
- W2007156779 cites W2399604190 @default.
- W2007156779 cites W2408872052 @default.
- W2007156779 cites W2409378240 @default.
- W2007156779 cites W2412936643 @default.
- W2007156779 cites W2415053867 @default.
- W2007156779 cites W2416678606 @default.
- W2007156779 cites W2419218868 @default.
- W2007156779 cites W285380630 @default.
- W2007156779 cites W46796727 @default.
- W2007156779 cites W53184713 @default.
- W2007156779 cites W2185437548 @default.
- W2007156779 cites W2418921658 @default.
- W2007156779 doi "https://doi.org/10.1007/s004670050692" @default.
- W2007156779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10603113" @default.
- W2007156779 hasPublicationYear "1999" @default.
- W2007156779 type Work @default.
- W2007156779 sameAs 2007156779 @default.
- W2007156779 citedByCount "72" @default.
- W2007156779 countsByYear W20071567792012 @default.
- W2007156779 countsByYear W20071567792013 @default.
- W2007156779 countsByYear W20071567792014 @default.
- W2007156779 countsByYear W20071567792017 @default.
- W2007156779 countsByYear W20071567792018 @default.
- W2007156779 countsByYear W20071567792019 @default.
- W2007156779 countsByYear W20071567792022 @default.
- W2007156779 crossrefType "journal-article" @default.
- W2007156779 hasAuthorship W2007156779A5027825347 @default.
- W2007156779 hasAuthorship W2007156779A5057866558 @default.
- W2007156779 hasAuthorship W2007156779A5069748177 @default.
- W2007156779 hasAuthorship W2007156779A5083465048 @default.
- W2007156779 hasBestOaLocation W20071567791 @default.
- W2007156779 hasConcept C104317684 @default.
- W2007156779 hasConcept C126322002 @default.
- W2007156779 hasConcept C142724271 @default.
- W2007156779 hasConcept C196166836 @default.
- W2007156779 hasConcept C203014093 @default.
- W2007156779 hasConcept C2522874641 @default.
- W2007156779 hasConcept C2776317777 @default.
- W2007156779 hasConcept C2776995267 @default.
- W2007156779 hasConcept C2777965375 @default.
- W2007156779 hasConcept C2779338263 @default.
- W2007156779 hasConcept C2779820661 @default.
- W2007156779 hasConcept C2780252810 @default.
- W2007156779 hasConcept C2911091166 @default.
- W2007156779 hasConcept C2992511266 @default.
- W2007156779 hasConcept C553184892 @default.
- W2007156779 hasConcept C55493867 @default.
- W2007156779 hasConcept C71924100 @default.
- W2007156779 hasConcept C86803240 @default.
- W2007156779 hasConcept C90924648 @default.
- W2007156779 hasConceptScore W2007156779C104317684 @default.
- W2007156779 hasConceptScore W2007156779C126322002 @default.
- W2007156779 hasConceptScore W2007156779C142724271 @default.
- W2007156779 hasConceptScore W2007156779C196166836 @default.
- W2007156779 hasConceptScore W2007156779C203014093 @default.
- W2007156779 hasConceptScore W2007156779C2522874641 @default.
- W2007156779 hasConceptScore W2007156779C2776317777 @default.
- W2007156779 hasConceptScore W2007156779C2776995267 @default.
- W2007156779 hasConceptScore W2007156779C2777965375 @default.
- W2007156779 hasConceptScore W2007156779C2779338263 @default.
- W2007156779 hasConceptScore W2007156779C2779820661 @default.
- W2007156779 hasConceptScore W2007156779C2780252810 @default.
- W2007156779 hasConceptScore W2007156779C2911091166 @default.
- W2007156779 hasConceptScore W2007156779C2992511266 @default.
- W2007156779 hasConceptScore W2007156779C553184892 @default.
- W2007156779 hasConceptScore W2007156779C55493867 @default.
- W2007156779 hasConceptScore W2007156779C71924100 @default.
- W2007156779 hasConceptScore W2007156779C86803240 @default.